medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Number 1

<< Back Next >>

Rev Invest Clin 2017; 69 (1)

Clinical and Demographic Predictors of Conversion to Dementia in Mexican Elderly with Mild Cognitive Impairment

Aguilar-Navarro SG, Mimenza-Alvarado AJ, Ávila-Funes JA, Juárez-Cedillo T, Bernal-López C, Hernández-Favela CG

Language: English
References: 35
Page: 33-39
PDF size: 176.73 Kb.


ABSTRACT

Background: Mild cognitive impairment (MCI) is considered a clinical stage between normal cognitive aging and dementia. The clinical course of MCI is heterogeneous, with a significant number of cases progressing to dementia or reverting back to normal. Objective: To determine the predictors of conversion from mild cognitive impairment to dementia among Mexican older adults. Materials and Methods: A sample of 175 persons underwent clinical and neuropsychological evaluation to establish mild cognitive impairment diagnosis. These patients were followed-up for a mean 3.5 years. Results: Mean age was 81.7 (± 6.9) years, 57% were women, and mean education level was 9.5 (± 6.1) years. Sixty-one percent of mild cognitive impairment participants progressed to dementia. Multivariate Cox regression analysis showed that progression to dementia was associated with age (HR: 4.95; 95% CI: 1.96-12.46; p = 0.001), low education level (HR: 5.81; 95% CI: 1.90-7.78; p ‹ 0.002), history of stroke (HR: 3.92; 95% CI: 1.37-11.16; p ‹ 0.012) and cognitive decline (HR: 1.31; 95% CI: 1.18-1.45; p = 0.000). Conclusions: Age, poor education, cognitive decline, and a history of stroke were predictors of conversion to dementia. The identification and control of modifiable risk factors could influence conversion to dementia.


REFERENCES

  1. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999; 56:303-8.

  2. Jak AJ, Preis SR, Beiser AS, et al. Neuropsychological criteria for mild cognitive impairment and dementia risk in the Framingham Heart Study. J Int Neuropsychol Soc. 2016;22:937-943.

  3. Petersen RC, Rosebud O, Roberts RO, et al. Mild cognitive impairment: ten years later. Arch Neurol. 2009;66:1447-55.

  4. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2014;9:63-75.

  5. Roberts R, Knopman DS. Classification and epidemiology of mild cognitive impairment. Clin Ger Med. 2013;29:753-72.

  6. Koepsell TD, Monsell SE. Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurology. 2012;79:1591-8.

  7. Campbell NL, Unverzagt F, LaMantia MA, Khan BA, Boustani MA. Risk factors for the progression of mild cognitive impairment to dementia. Clin Ger Med. 2013;29:873-93.

  8. Prince M, Albanese E, Guerchet M, Prina M. World Alzheimer’s Report 2014: Dementia and risk reduction. An analysis of protective and modifiable factors. Public health priority. [e-journal] 2014. Available at: www.alz.co.uk/research/ [Accessed November 10, 2014].

  9. Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State” a practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res. 1975;12:189-98.

  10. Morris J. The clinical dementia rating (CDR): Current version and scoring rules. Neurology. 1993;43:2412-14.

  11. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychological function. JAMA. 1963;185:914-19.

  12. L awton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-86.

  13. Petersen RC. Clinical practice. Mild cognitive impairment. N Engl J Med. 2011;364:2227-2234.

  14. Dubois B, Touchon J, Portet F, Ousset PJ, Vellas B, Michel B. The 5 words’: A simple and sensitive test for the diagnosis of Alzheimer’s disease. Presse Med. 2002;31:1696-9.

  15. Canning SJ, Leach L, Stuss D, Ngo L, Black SE. Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia. Neurology. 2004;62:556-62.

  16. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: A frontal assessment battery at bedside. Neurology. 2000;55:1621-6.

  17. Shulman KI. Clock-drawing: Is it the ideal cognitive screening test? Int J Geriatr Psychiatry. 2000;15:548-61.

  18. A merican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision (DSM-IV-TR) Barcelona: Masson. 2002.

  19. Pohjasvaara T, Mantyla R, Ylikoski R, Kaste M, Erkinjuntti T. Comparison of different clinical criteria (DSM-III, ADDTC, ICD- 10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke- Association Internationale pour la Recherche et I’ Enseignement en Neurosciences. Stroke. 2000;31:2952-7.

  20. N eary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-54.

  21. McKeith I, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863-72.

  22. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDSAIREN International Workshop. Neurology. 1993;43:250-60.

  23. O ´Connor PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med. 1998;338:592-602.

  24. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiat Res. 1982;17:34-7.

  25. Katz Mj, Lipton RB, Hall CB, et al. Age and sex specific prevalence and incidence of mild cognitive impairment, dementia and Alzheimer’s dementia in blacks and whites: A report from The Einstein Aging Study. Alzheimer Dis Assoc Disord. 2012;26:335-43.

  26. Vos SJ, Xiong C, Visser PJ, et al. Preclinical Alzheimer’s disease and its outcome: a longitudinal cohort study. Lancet Neurol. 2013;12:957-65.

  27. Solfrizzi V, Panza F, Colacicco AM, et al. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology. 2004;63:1882-91.

  28. Mejia-Aranjo S, Gutiérrez-Robledo LM. Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the Mexican Health and Aging Study. J Aging Health. 2011;23:1050-74.

  29. Sosa AL, Albanese E, Stephan BC, et al. Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China and India: A 10/66 Population-Based Study. PLoS Med. 2012;9: e1001170.

  30. Cooper C, Sommerlad A, Lyketsos CG, et al. Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am J Psychiatry. 2015;172:323-34.

  31. Ding D, Zhao O, Guo Q, et al. Progression and predictors of mild cognitive impairment in Chinese elderly: A prospective follow-up in the Shanghai Aging Study. Alzheimers Dement (Amst). 2016; 4:28-36.

  32. Inselberg R, Massarwa M, Schechtman E, Strugatsky R, Farrer LA, Friedland RP. Estimating the risk for conversion from mild cognitive impairment to Alzheimer’s disease in an elderly Arab community. J Alzheimers Dis. 2015;45:865-71.

  33. L i J, Wanj YJ, Zhang M, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76:1485-91.

  34. Bejot Y, Aboa-Eboulé C, Durier J, et al. Prevalence of early dementia after first-ever stroke: a 24-year population based study. Stroke. 2011;42:607-12.

  35. Khedr EM, Hamed SA, El-Shereef HK, et al. Cognitive impairment after cerebrovascular stroke: relationship to vascular risk factors. Neuropsychiatr Dis Treat. 2009;5:103-16.




2020     |     www.medigraphic.com